Home > Boards > US Listed > Biotechs > Actinium Pharmaceuticals, Inc. (ATNM)

News: $ATNM Actinium Successfully Completes Second Module of

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
 
Followed By 46
Posts 5,811
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2019 5:03:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/16/2019 5:19:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/16/2019 5:17:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/16/2019 5:14:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/16/2019 5:11:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/16/2019 5:07:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/16/2019 5:03:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/16/2019 4:59:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/16/2019 4:59:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/16/2019 4:56:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 5:05:42 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 4:58:07 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 5/10/2019 4:51:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/18/2019 5:25:44 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 4/18/2019 5:08:23 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 4/18/2019 11:52:54 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 4/17/2019 4:18:04 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/15/2019 5:05:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/12/2019 5:26:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/7/2019 4:52:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/21/2019 4:48:55 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 2:20:32 PM
Actinium Initiates Novel Phase 1/2 Combination Trial of Actimab-A and Venetoclax PR Newswire (US) - 2/5/2019 8:00:00 AM
Actinium Initiates Second Dosing Cohort of Novel Combination Trial with Actimab-A and CLAG-M Salvage Regimen at Medical Colle... PR Newswire (US) - 2/4/2019 8:00:00 AM
Actinium Pharmaceuticals to Host Key Opinion Leader Breakfast on Targeted Conditioning for Bone Marrow Transplant and CAR-T o... PR Newswire (US) - 1/29/2019 8:00:00 AM
whytestocks   Friday, 03/29/19 04:00:38 PM
Re: None
Post # of 1687 
News: $ATNM Actinium Successfully Completes Second Module of Collaborative Research Program with Astellas; Third Module Initiated

NEW YORK , March 29, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.   (NYSE AMERICAN: ATNM) announced today that it has successfully completed the second module of its previously announced research and option agreement with Astellas Pharma Inc. and that the third module has bee...

Read the whole news https://marketwirenews.com/news-releases/actinium-successfully-completes-second-module-of-collaborative-research-program-with-astellas-third-module-initiated-7912462.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist